|

[89Zr]DFO-YS5 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 89Zirconium-89 DFO conjugated to the YS5 monoclonal antibody

Pipeline

Phase 1: 1

Top Sponsors

  • Robert Flavell, MD, PhD1

Indications

  • Nerve Sheath Tumor, Nos1
  • Solid Tumor Neoplasms1
  • Nerve Sheath Tumors1
  • Nerve Sheath Tumor1
  • Bladder Neoplasm1

San Francisco, California1 trial

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

University of California, San Francisco

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.